Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating insomnia

A technology for insomnia and medicine, applied in the field of medicine, can solve the problems of difficult to achieve therapeutic effect, cure the symptoms but not the root cause, and the effect is uncertain, and achieve the effects of reducing economic burden, not easy to recur, and short course of treatment

Active Publication Date: 2012-05-09
如东文园投资开发有限公司
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it is difficult for general Chinese medicines to achieve theoretical therapeutic effects due to limited conditions. Some of them treat the symptoms but not the root cause, and some are discontinued due to uncertain curative effects during the application process. In addition, there are technical problems of poor pertinence.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] A pharmaceutical composition for treating insomnia, which is prepared from the following raw materials in proportion by weight,

[0037] Albizia julibrissin 20 parts, Angelica 20 parts, Rehmannia glutinosa 18 parts, Ophiopogon japonicus 15 parts,

[0038] 12 parts of Guizhi, 12 parts of Chuanxiong, 15 parts of Scrophulariaceae, 9 parts of Ligustrum lucidum,

[0039] Astragalus 9 parts, Anemarrhena 10 parts, Suanzaoren 8 parts, Pinellia 8 parts,

[0040] Cyperus 9 parts, Coptidis 7 parts, Poria cocos 7 parts, Cassia seed 5 parts.

Embodiment 2

[0042] Get the crude drug of above-mentioned each weight portion by the ratio of embodiment 1 for subsequent use;

[0043] Add 8 times the amount of water and decoct 3 times, 2 hours each time, filter, combine the filtrate, and concentrate to an extract with a density of 1.12g / ml;

[0044] After drying at 50-60°C, crush to 120-mesh medicinal powder, pack into capsules, and sterilize to obtain capsule preparations.

[0045] Three times a day, 5 capsules each time, 2 weeks as a course of treatment. Avoid spicy and cold food while taking the medicine, avoid emotional stimulation, and have a regular life.

Embodiment 3

[0047] clinical information

[0048] Cases were selected with reference to the "Expert Consensus on Definition, Diagnosis, and Drug Therapy of Insomnia (Draft)" and "Chinese Classification and Diagnostic Criteria for Mental Disorders (CCMD-3)" to formulate the following criteria: ①Long sleep latency: sleep time of more than 30 minutes; ②Sleep maintenance Obstacles: more than 2 awakenings at night; ③decreased sleep quality: shallow sleep, dreaminess; ④ shortened total sleep time: less than 5 hours; Wait.

[0049] Exclusion criteria:

[0050] ① Those who are under 18 years old and over 65 years old; ② Those with severe physical illness and severe mental illness; ③ Those who use other drugs and antipsychotic drugs; ④ Those who have serious suicide attempts and behaviors; ⑤ Pregnant and lactating women; ⑥ Those who do not cooperate with treatment.

[0051] 97 outpatient cases were randomly selected as the treatment group, 39 males and 58 females, aged 19-65 years, with an avera...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine for treating insomnia. Raw materials of the medicine comprise, by weight, 20 parts of Flos Albiziae, 20 parts of Angelica sinensis, 18 parts of Radix Rehmanniae, 15 parts of Radix Ophiopogonis, 12 parts of Ramulus Cinnamomi, 12 parts of Ligusticum chuanxiong Hort, 15 parts of Radix Scrophulariae, 9 parts of Radix astragali, 10 parts of Anemarrhena asphodeloides, 8 parts of seed of wild jujube, 8 parts of Pinellia ternate, 9 parts of Rhizoma cyperi, 7 parts of rhizoma coptidis, 7 parts of Poria cocos and 5 parts of semen cassiae. It has been clinically verified that the medicinal composite for treating insomnia has efficacy of treating insomnia, is nontoxic and harmless to human body, can be used to treat both principal and secondary aspect of disease, has no side effect, is low-priced, is simple to prepare, and has an extensive application prospect.

Description

technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to a pharmaceutical composition for treating insomnia and a preparation method thereof. Background technique [0002] Insomnia refers to difficulty in falling asleep, easy awakening at night, short sleep time, and even difficulty sleeping all night, accompanied by a series of neuropsychiatric symptoms. It is a common clinical disease and frequently-occurring disease. Insomnia is a manifestation of the imbalance of yin and yang in viscera, which is called "insomnia", "inability to sleep", "inability to lie down", "unable to close eyes" in traditional Chinese medicine. In recent years, with the rapid development of social economy and the acceleration of the pace of life, the social environment has undergone tremendous changes, which has brought tension, pressure and competition to people's life and work, directly affecting people's physical and mental health, long-term t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8968A61P25/20
Inventor 管銮友
Owner 如东文园投资开发有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com